A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report
The citation for this report is:
Berger M, Martin B, Husereau D, et al, A questionnaire to assess the relevance and credibility of observational studies to inform healthcare decision making: an ISPOR-AMCP-NPC good practice task force report. Value Health 2014; 17:143-156.
Bradley Martin PhD, RPh, PharmD , Task Force Chair and Professor and Division Chair, College of Pharmacy, University of Arkansas for Medical Sciences, Department of Pharmacy Practice, Little Rock, AR, USA, (ISPOR)
Winnie Yang, PharmD, Director, Pharmacy Product, Strategy and Analytics Blue Shield of California Woodland Hills, CA, USA (AMCP)
Eric Cannon, PharmD, FAMCP, Chief of Pharmacy SelectHealth, Murray, Utah, USA (AMCP)
Kristijan Kahler, PhD, RPh, Head, HEOR Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA (NPC)
Nicole C. Quon, PhD, Senior Director, Healthcare Quality, Optimer Pharmaceuticals, Inc. Jersey City, NJ, USA (NPC)
William Crown, PhD, Senior Scientific Officer, OptumLabs, Cambridge, MA USA (ISPOR)
Michael Johnson, PhD, Associate Professor University of Houston, College of Pharmacy, Houston, TX , USA (ISPOR)
The task force sent out drafts for review twice during the development process. All comments were read and addressed as appropriate.
The task force presented their findings during the Third Plenary Session at the ISPOR 18th Annual International Meeting, New Orleans, LA, USA in May 2013